World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care - PubMed (original) (raw)

Review

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

Michael Bauer et al. World J Biol Psychiatry. 2007.

Abstract

These practical guidelines for the biological treatment of unipolar depressive disorders in primary care settings were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). They embody the results of a systematic review of all available clinical and scientific evidence pertaining to the treatment of unipolar depressive disorders and offer practical recommendations for general practitioners encountering patients with these conditions. The guidelines cover disease definition, classification, epidemiology and course of unipolar depressive disorders, and the principles of management in the acute, continuation and maintenance phase. They deal primarily with biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy).

PubMed Disclaimer

Comment in

Updated WFSBP Guidelines for the Biological Treatment of Unipolar Depressive Disorders in Primary Care.
Bauer M. Bauer M. World J Biol Psychiatry. 2007;8(2):66. doi: 10.1080/15622970701308413. World J Biol Psychiatry. 2007. PMID: 17455101 No abstract available.

Cited by

The involvement of K+ channels in depression and pharmacological effects of antidepressants on these channels.
Li XT. Li XT. Transl Psychiatry. 2024 Oct 2;14(1):411. doi: 10.1038/s41398-024-03069-6. Transl Psychiatry. 2024. PMID: 39358318 Free PMC article. Review.
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.
Nakamura T, Furihata R, Hasegawa N, Kodaka F, Muraoka H, Ichihashi K, Ochi S, Numata S, Tsuboi T, Makinodan M, Iida H, Onitsuka T, Kashiwagi H, Takeshima M, Hashimoto N, Nagasawa T, Usami M, Yamagata H, Takaesu Y, Miura K, Matsumoto J, Ohi K, Yamada H, Hori H, Inada K, Watanabe K, Hashimoto R, Yasui-Furukori N. Nakamura T, et al. BMC Psychiatry. 2024 May 29;24(1):399. doi: 10.1186/s12888-024-05816-x. BMC Psychiatry. 2024. PMID: 38807065 Free PMC article.
Basmisanil, an α5-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice.
Daher F, Villalobos NA, Hanley M, Atack JR, Popa MO, Fogaça MV. Daher F, et al. Neurosci Lett. 2024 Jun 11;833:137828. doi: 10.1016/j.neulet.2024.137828. Epub 2024 May 19. Neurosci Lett. 2024. PMID: 38772437
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder.
Su WJ, Hu T, Jiang CL. Su WJ, et al. Curr Neuropharmacol. 2024;22(5):810-842. doi: 10.2174/1570159X21666230809112028. Curr Neuropharmacol. 2024. PMID: 37559243 Free PMC article. Review.
A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients.
Seemüller F, Schennach R, Musil R, Obermeier M, Adli M, Bauer M, Brieger P, Laux G, Gaebel W, Falkai P, Riedel M, Möller HJ. Seemüller F, et al. BMC Psychiatry. 2023 Jul 28;23(1):548. doi: 10.1186/s12888-023-05038-7. BMC Psychiatry. 2023. PMID: 37507656 Free PMC article.

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care - PubMed (original) (raw)